| Financial Year |
March 31 2023 |
| Monetary Funds |
782,115,439.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
37,185,274.71 |
| Accounts Receivable |
526,515,217.18 |
| Advances to Suppliers |
10,340,495.11 |
| Other Receivables |
26,435,708.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
317,289,570.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,537,221.62 |
| Total Current Assets |
1,709,788,613.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
39,736,977.07 |
| Investment Properties |
39,774,228.85 |
| Fixed Assetes |
695,015,380.13 |
| Under-construction Projects |
29,276,789.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
117,655,903.19 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
12,992,270.87 |
| Other Non-Current Assets |
19,108,969.60 |
| Sub-Total of Non-Current Assets |
1,045,491,835.38 |
| Total Assets |
2,755,280,448.63 |
| Short-Term Loans |
130,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
174,340,321.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,790,207.35 |
| Taxes Payable |
8,309,104.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,241,983.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
80,384,403.21 |
| Other Current Liabilities |
101,498.82 |
| Sub-Total of Current Liabilities |
471,602,403.14 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,563,262.70 |
| Total Liabilities |
487,165,665.84 |
| Paid-In Capital(Or Share Stock) |
196,052,780.00 |
| Capital Surplus |
1,098,375,296.54 |
| Surplus Reserve |
111,246,710.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
813,971,388.10 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,268,114,782.79 |
| Owner's Equity（Stockholder's Equity） |
2,268,114,782.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,755,280,448.63 |
